Integration of machine learning and experimental validation to identify the prognostic signature related to diverse programmed cell deaths in breast cancer.

Journal: Frontiers in oncology
Published Date: Jan 6, 2025

Abstract

BACKGROUND: Programmed cell death (PCD) is closely related to the occurrence, development, and treatment of breast cancer. The aim of this study was to investigate the association between various programmed cell death patterns and the prognosis of breast cancer (BRCA) patients.

Authors

  • Longpeng Li
    Department of Anesthesiology, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China.
  • Jinfeng Zhao
    Institute of Physical Education and Sport, Shanxi University, Taiyuan, China.
  • Yaxin Wang
    Institute of Physical Education and Sport, Shanxi University, Taiyuan, China.
  • Zhibin Zhang
    Institute of Physical Education and Sport, Shanxi University, Taiyuan, China.
  • Wanquan Chen
    Institute of Physical Education and Sport, Shanxi University, Taiyuan, China.
  • Jirui Wang
    Institute of Physical Education and Sport, Shanxi University, Taiyuan, China.
  • Yue Cai
    Department of Anesthesiology, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals